Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 25;18(7):pyv016.
doi: 10.1093/ijnp/pyv016.

Extensive gray matter volume reduction in treatment-resistant schizophrenia

Valerie M Anderson  1 , Meghan E Goldstein  1 , Robert R Kydd  1 , Bruce R Russell  2
Affiliations

Extensive gray matter volume reduction in treatment-resistant schizophrenia

Valerie M Anderson et al. Int J Neuropsychopharmacol. .

Abstract

Background: Approximately one-third of people with schizophrenia are treatment-resistant and some do not achieve remission with clozapine, the gold-standard antipsychotic medication for treatment-resistant schizophrenia. This study compared global and regional brain volumes between treatment-respondent and treatment-resistant patients with schizophrenia, including a group of patients who were clozapine-resistant.

Methods: T1-weighted brain MRIs were obtained on a 3T scanner in 20 controls and 52 people with schizophrenia who were selected based on their symptomatic responses to antipsychotic medication: 18 responded well to first-line atypical antipsychotics (FLR), 19 were treatment-resistant but responsive to clozapine monotherapy (TR), and 15 were ultra-treatment-resistant and did not respond to clozapine (UTR). Treatment groups were matched for disease duration and current psychopathology. SIENAX and FSL-VBM were used to investigate differences in the global brain, gray matter (GM), white matter, ventricular cerebrospinal fluid volumes, and regional GM volumes.

Results: GM volume was significantly reduced in the TR and UTR groups compared with controls and the FLR group (p < 0.05). GM volume was significantly reduced in TR patients compared with FLRs in the superior, middle, and inferior temporal gyri, pre- and post-central gyri, middle and superior frontal gyri, right supramarginal gyrus, and right lateral occipital cortex. UTR patients showed reduced GM compared with FLRs in their right parietal operculum and left cerebellum. No significant volume differences were observed between TR and UTR groups.

Conclusions: These differences are unlikely to be solely due to medication effects, and reduced GM volume in treatment-resistant schizophrenia may represent an accelerated disease course or a different underlying pathology.

Keywords: MRI; clozapine; treatment-resistant schizophrenia; voxel-based morphometry.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Reduced gray matter in ultra-treatment-resistant patients compared with controls, overlaid on the MNI-152 template brain.
Figure 2.
Figure 2.
Reduced gray matter in treatment-resistant patients compared with first-line antipsychotic responders, overlaid on the MNI-152 template brain.
See this image and copyright information in PMC

References

    1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association.
    1. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J, American Psychiatric Association, Steering Committee on Practice Guidelines (2004). Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psych 161:1–56. - PubMed
    1. Andreasen NC, Pierson R ( 2008). The role of the cerebellum in schizophrenia. Biol Psychiatry 64:81–88. - PMC - PubMed
    1. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC ( 2010). Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 67:255– 262. - PMC - PubMed
    1. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC ( 2011). Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 70:672–679. - PMC - PubMed

Publication types

MeSH terms